A detailed history of Northern Trust Corp transactions in Catalent, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 1,583,297 shares of CTLT stock, worth $93.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,583,297
Previous 1,627,201 2.7%
Holding current value
$93.6 Million
Previous $91.5 Million 4.81%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$56.16 - $60.96 $2.47 Million - $2.68 Million
-43,904 Reduced 2.7%
1,583,297 $95.9 Million
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $1 Million - $1.06 Million
-18,666 Reduced 1.13%
1,627,201 $91.5 Million
Q1 2024

May 14, 2024

SELL
$42.56 - $59.82 $17.5 Million - $24.6 Million
-410,899 Reduced 19.98%
1,645,867 $92.9 Million
Q4 2023

Feb 13, 2024

SELL
$32.18 - $46.57 $3.34 Million - $4.84 Million
-103,837 Reduced 4.81%
2,056,766 $92.4 Million
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $11.4 Million - $13 Million
258,482 Added 13.59%
2,160,603 $98.4 Million
Q2 2023

Aug 11, 2023

SELL
$31.86 - $67.26 $6.03 Million - $12.7 Million
-189,201 Reduced 9.05%
1,902,121 $82.5 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $9.08 Million - $14.8 Million
199,884 Added 10.57%
2,091,322 $137 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $5.31 Million - $10.4 Million
128,253 Added 7.27%
1,891,438 $85.1 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $4.05 Million - $6.34 Million
-56,028 Reduced 3.08%
1,763,185 $128 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $11.1 Million - $14.5 Million
127,056 Added 7.51%
1,819,213 $195 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $2.09 Million - $2.76 Million
22,177 Added 1.33%
1,692,157 $188 Million
Q4 2021

Feb 08, 2022

SELL
$119.57 - $139.07 $678,081 - $788,665
-5,671 Reduced 0.34%
1,669,980 $214 Million
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $41,266 - $53,808
-378 Reduced 0.02%
1,675,651 $223 Million
Q2 2021

Aug 13, 2021

BUY
$100.34 - $115.69 $1.12 Million - $1.29 Million
11,115 Added 0.67%
1,676,029 $181 Million
Q1 2021

May 12, 2021

BUY
$101.51 - $125.27 $1.22 Million - $1.51 Million
12,044 Added 0.73%
1,664,914 $175 Million
Q4 2020

Feb 11, 2021

SELL
$85.88 - $105.36 $879,840 - $1.08 Million
-10,245 Reduced 0.62%
1,652,870 $172 Million
Q3 2020

Nov 16, 2020

BUY
$72.74 - $92.5 $13.7 Million - $17.5 Million
188,943 Added 12.82%
1,663,115 $142 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $11.4 Million - $18.8 Million
237,361 Added 19.19%
1,474,172 $108 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $3.65 Million - $6.21 Million
98,661 Added 8.67%
1,236,811 $64.3 Million
Q4 2019

Feb 14, 2020

BUY
$47.06 - $56.64 $1.02 Million - $1.23 Million
21,630 Added 1.94%
1,138,150 $64.1 Million
Q3 2019

Nov 13, 2019

SELL
$47.45 - $58.05 $1.02 Million - $1.24 Million
-21,398 Reduced 1.88%
1,116,520 $53.2 Million
Q2 2019

Aug 13, 2019

SELL
$39.26 - $54.21 $367,198 - $507,026
-9,353 Reduced 0.82%
1,137,918 $61.7 Million
Q1 2019

May 13, 2019

BUY
$29.84 - $43.92 $1.24 Million - $1.83 Million
41,563 Added 3.76%
1,147,271 $46.6 Million
Q4 2018

Feb 12, 2019

BUY
$29.95 - $46.34 $215,969 - $334,157
7,211 Added 0.66%
1,105,708 $34.5 Million
Q3 2018

Nov 14, 2018

BUY
$40.12 - $45.55 $147,641 - $167,624
3,680 Added 0.34%
1,098,497 $50 Million
Q2 2018

Sep 18, 2018

SELL
$38.72 - $42.52 $336,941 - $370,009
-8,702 Reduced 0.79%
1,094,817 $45.9 Million
Q2 2018

Aug 14, 2018

SELL
$38.72 - $42.52 $35.8 Million - $39.3 Million
-925,153 Reduced 45.6%
1,103,519 $46.2 Million
Q1 2018

May 09, 2018

BUY
$39.4 - $47.39 $86,443 - $103,973
2,194 Added 0.11%
2,028,672 $83.3 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $168,758 - $194,794
4,528 Added 0.22%
2,026,478 $83.2 Million
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $68.2 Million - $84.3 Million
2,021,950
2,021,950 $80.7 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.